acetylphenylalanamide has been researched along with p-chloroamphetamine in 1 studies
| Studies (acetylphenylalanamide) | Trials (acetylphenylalanamide) | Recent Studies (post-2010) (acetylphenylalanamide) | Studies (p-chloroamphetamine) | Trials (p-chloroamphetamine) | Recent Studies (post-2010) (p-chloroamphetamine) |
|---|---|---|---|---|---|
| 5 | 0 | 4 | 656 | 0 | 31 |
| Protein | Taxonomy | acetylphenylalanamide (IC50) | p-chloroamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.207 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, R; Jiang, Y; Kim, Y; Lee, JH; Lee, MJ; Lee, SH; Mai, BK; Sriram, S; Yoo, YD | 1 |
1 other study(ies) available for acetylphenylalanamide and p-chloroamphetamine
| Article | Year |
|---|---|
Development and characterization of monomeric N-end rule inhibitors through in vitro model substrates.
Topics: Drug Design; Enzyme Inhibitors; Models, Molecular; Protein Conformation; Stereoisomerism; Ubiquitin-Protein Ligases | 2013 |